ZURA vs CLYM

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 10, 2026

ZURA

42.4
AI Score
VS
ZURA Wins

CLYM

41.5
AI Score

Investment Advisor Scores

ZURA

42score
Recommendation
HOLD

CLYM

42score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ZURA CLYM Winner
Net Income -41.79M -76.35M CLYM
Operating Income -47.46M -83.59M CLYM
ROE -18.3% -75.2% CLYM
ROA -17.7% -39.2% CLYM
Total Assets 236.56M 194.63M CLYM
Cash 39.73M 187.65M ZURA
Current Ratio 26.58 11.29 CLYM
Free Cash Flow -38.01M -59,395 ZURA

Relative Price Performance (Last 90 Days)

ZURA 1M: -64.9% · 3M: -75.7% CLYM 1M: +8.4% · 3M: -18.4%

Current Technical Phase

ZURA

Markdown
Sell / avoid

Price below a falling SMA50 (slope -16.4%), weak momentum, RSI 27

RSI (14): 26.8 · Price: $1.41

CLYM

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 58

RSI (14): 58.3 · Price: $11.74

Fundamentals Snapshot

Metric ZURA CLYM
Market Cap — —
Forward P/E -2.1 -11.7
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin — —
Operating Margin 0.0% 0.0%
EPS -1.11 -0.87
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, ZURA is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.